EMEA recommends approval of two swine flu vaccines
This article was originally published in SRA
Executive Summary
The global preventive response to the 2009 H1N1 influenza A (swine flu) virus, through the accelerated development and approval of vaccines, is moving forward. The European Medicines Agency is the latest drug regulatory authority to recommend approval of two H1N1 vaccines1.